Appointment of Aquis Corporate Adviser

Summary by AI BETAClose X

ProBiotix Health PLC announced the appointment of AlbR Capital Limited as its Aquis Corporate Adviser, effective immediately on October 23, 2025. The company, which focuses on developing probiotics to support cardiometabolic health, is listed on AQSE under the ticker PBX. This appointment is intended to bolster ProBiotix's corporate advisory resources as it continues its work in microbiome modulating probiotics.

Disclaimer*

Probiotix Health PLC
23 October 2025
 

23 October 2025

 

ProBiotix Health plc

("ProBiotix" or the "Company" or, together with its subsidiary, the "Group")

 

Appointment of Aquis Corporate Adviser

 

ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, is pleased to announce that AlbR Capital Limited has been appointed as Aquis Corporate Adviser to the Company with immediate effect.

 

For further information, please contact:

 

ProBiotix Health plc

https://probiotixhealth-ir.com/

 

investors@probiotixhealth.com

Steen Andersen, Chief Executive Officer

Miles Nolan, Investor Relations

 



AlbR Capital Limited

 

Aquis Corporate Adviser and Broker

Tel: 020 7469 0930



Notes to Editors:

 

ProBiotix is a life sciences company that develops probiotic formulations to support cardiometabolic health. Since its formation, ProBiotix has become recognised as a global leader in microbiome modulating probiotics for use in food supplements and nutraceuticals.

 

The Company has a singular approach: discovering ground breaking probiotics, ensuring their benefits through robust science, and bringing to market effective finished probiotic-based products for human health across the globe.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

ProBiotix Health Plc (PBX)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today